FDA News Release. The U.S. Food and Drug Administration approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a…

The 2015 International LAM Scientific and Patient Conference will take place in Chicago, USA, from March 27th…

On November 13 -15 an exceptional group of biomarker scientists with diverse expertise gathered in Atlanta, GA,…

For the second year in a row Antoine Salles, Chef and owner of French Bistrot “Touquet” in O’Connell…

The LAM Trust invites you to the Annual Gift Of Music Charity Concert by the Renowned Concert Pianist Mi-Yeon…

Following on from the very successful Short Course on Rare Lung Disease, hosted by the Australian Lung…

LAM Therapeutics launches operations to develop drugs for rare lung disease, Lymphangioleiomyomatosis (LAM). LAM Therapeutics, the first…

The Impact of Rare Diseases: in New Zealand and Internationally. Rare Diseases are conditions that affect a…

The Annual LAM patient and scientific meeting was held in Cincinnati, Ohio, USA, April 12/13/14 2013. More…

Bronwyn Gray, the NZ LAM Trust’s Director met recently in Melbourne with LAM patient, Heather Telford, immediate…